---
title: "B细胞促进肿瘤进展"
date: 2024-11-28T06:54:55Z
draft: ["false"]
tags: [
  "fetched",
  "闲谈 Immunology"
]
categories: ["Acdemic"]
---
B细胞促进肿瘤进展 by 闲谈 Immunology
------
<div><p data-mpa-powered-by="yiban.io"><img data-galleryid="" data-imgfileid="100038971" data-ratio="0.24722222222222223" data-s="300,640" data-type="png" data-w="1080" data-src="https://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicQcON5mBj4U2Nq1Rjw4hx1mJyBJicnGYlY0hQMjKu109eVRTtsPbzDedb6uMDM7D4XdFXOXHK3jUVg/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicQcON5mBj4U2Nq1Rjw4hx1mJyBJicnGYlY0hQMjKu109eVRTtsPbzDedb6uMDM7D4XdFXOXHK3jUVg/640?wx_fmt=png&amp;from=appmsg"></p><section><span></span></section><section><span>B细胞是形成三级淋巴样结构（TLS）的主要细胞成分，被认为是免疫治疗疗效最好的细胞标志物（</span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=Mzg2OTczNjI0OQ==&amp;mid=2247489297&amp;idx=1&amp;sn=0d223e56fdca4d5043c2fb9030f87e03&amp;chksm=ce99dd47f9ee545137c19e19d63adb062031e53b1318bcf824013cdd3c70f35737dce5364058&amp;scene=21#wechat_redirect" textvalue="有效区分“应答患者”和“无应答患者”，B细胞在Immunoscore中的价值" linktype="text" imgurl="" imgdata="null" data-itemshowtype="11" tab="innerlink" data-linktype="2"><span>有效区分“应答患者”和“无应答患者”，B细胞在Immunoscore中的价值</span></a><span>）。但是对于<span><strong>T细胞肿瘤</strong></span>，B细胞可能就会体现出促进肿瘤的一面。最近一项研究，证实了一点。</span></section><section><span><strong><span>皮肤T细胞淋巴瘤</span></strong></span></section><section><span>皮肤T细胞淋巴瘤（cutaneous T-cell lymphoma, CTCL）属于结外非何杰金淋巴瘤（Non-Hodgkin’s lymphoma, NHL）中的一种，是原发于皮肤的由T淋巴细胞克隆性增生造成的疾病，由一组临床表现、组织学特征、及病程预后各不相同的疾病组成。皮肤T细胞淋巴瘤占所有原发性皮肤淋巴瘤的75%-80%。<span>其中蕈样肉芽肿是最常见的亚型，在美国发病率为百万分之 5.42。</span></span></section><section><span>早期蕈样肉芽肿（I-IIA 期）通常在皮肤上表现为斑块和斑片，可能被误诊为良性炎症性疾病，如特应性皮炎（AD）和银屑病，这给临床和组织学诊断带来了挑战。尽管大多数患者病情进展缓慢，但三分之一的早期蕈样肉芽肿患者可进展为晚期疾病（≥IIB 期），总体生存率较低。晚期蕈样肉芽肿中的恶性 T 细胞通常是中央记忆样 CD4 + 克隆，具有供体间高变异性和高肿瘤突变负荷的特点，但对其分子特征了解甚少。</span></section><section><span><strong><span>B细胞与<span>皮肤T细胞淋巴瘤</span></span></strong></span></section><section><strong><span>B细胞在CTCL肿瘤部位富集，形成TLS。</span></strong></section><p><img data-galleryid="" data-imgfileid="100039405" data-ratio="0.6935185185185185" data-s="300,640" data-type="png" data-w="1080" data-src="https://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicT8xWqiad9jicKSeaYo8nI1DMu1REt98fUHJ1tMibz116c1jxaZzPoamCll0OoWQ9n2gAZlEBgticg1uQ/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicT8xWqiad9jicKSeaYo8nI1DMu1REt98fUHJ1tMibz116c1jxaZzPoamCll0OoWQ9n2gAZlEBgticg1uQ/640?wx_fmt=png&amp;from=appmsg"></p><section><strong><span>B细胞富集度越高，PFS时间越短。</span></strong><br></section><p><img data-galleryid="" data-imgfileid="100039407" data-ratio="0.6454372623574145" data-s="300,640" data-type="png" data-w="1052" data-src="https://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicT8xWqiad9jicKSeaYo8nI1DMd9zmTR0DT1loCvgF4MlGDCPzBFF2G6bPRyKpD4amf0kM0a5e5lIvOw/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicT8xWqiad9jicKSeaYo8nI1DMd9zmTR0DT1loCvgF4MlGDCPzBFF2G6bPRyKpD4amf0kM0a5e5lIvOw/640?wx_fmt=png&amp;from=appmsg"></p><section><strong><span>B细胞可能促进了CTCL进展。</span></strong><br></section><p><img data-galleryid="" data-imgfileid="100039406" data-ratio="0.6342794759825328" data-s="300,640" data-type="png" data-w="916" data-src="https://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicT8xWqiad9jicKSeaYo8nI1DM80iaD8KXffGaUCfKAso39vSbkCpt225dOA11EvCYj9PbNUMPNUsVzow/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicT8xWqiad9jicKSeaYo8nI1DM80iaD8KXffGaUCfKAso39vSbkCpt225dOA11EvCYj9PbNUMPNUsVzow/640?wx_fmt=png&amp;from=appmsg"></p><section><br></section><section><span>参考资料</span></section><section><span>Ruoyan Li et al， Cutaneous T cell lymphoma atlas reveals malignant TH 2 cells supported by a B cell-rich tumor microenvironment， Nat Immunol. 2024 Nov 18. doi: 10.1038/s41590-024-02018-1</span></section><section><span>: Kwantwi, L.B.; Rosen, S.T.;Querfeld, C. The TumorMicroenvironment as a TherapeuticTarget in Cutaneous T CellLymphoma. Cancers 2024, 16, 3368.https://doi.org/10.3390/cancers16193368</span></section><section><mp-common-profile data-pluginname="mpprofile" data-id="Mzg2OTczNjI0OQ==" data-headimg="http://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicSUg9Zeq93L0JONScSZFlntu2ygj7iaq0trvU3x8sot8hpJ5U6PmtPsys5kiaqkTv364qWAdIQgqoSQ/0?wx_fmt=png" data-nickname="闲谈 Immunology" data-alias="xiantanimmunology" data-signature="专注ImmunoBiology，桥接基础研究与产业应用！" data-from="0" data-service_type="1"></mp-common-profile></section><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/BZZpZHjxxRNWUGmRjxoVtA",target="_blank" rel="noopener noreferrer">原文链接</a>
